Entasis Therapeutics Holdings Inc (ETTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETTX | GLYC | NOTV | ||
| Company | Entasis Therapeutics Holdings Inc | Glycomimetics Inc | Inotiv Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.19 | 1.6400 | 4.19 | ||
| High | 2.20 | 1.7300 | 4.21 | ||
| Low | 2.19 | 1.5400 | 3.74 | ||
| Last | 2.19 | 1.5500 | 3.74 | ||
| Change | -0.01 | -0.0900 | -0.31 | ||
| % Change | -0.45% | -5.49% | -7.65% | ||
| Volume | 68,800 | 1,141,400 | 617,000 | ||
| 20-Day Average Volume | 116,305 | 776,840 | 537,150 | ||
| Previous Close | 2.20 | 1.6400 | 4.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.19 | 2.2485 | 5.97 | ||
| 20-Day Raw Stochastic | 50.00% | 0.62% | 0.00% | ||
| 20-Day Relative Strength | 63.74% | 29.71% | 32.20% | ||
| Weighted Alpha | -10.90 | -28.93 | -40.56 | ||
| Today's Opinion | 32% Buy | 40% Sell | 8% Sell | ||
| Previous Opinion | 40% Buy | 24% Sell | 8% Sell | ||
| Last Month's Opinion | 24% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.45% since 06/30/22 | -13.89% since 04/22/24 | -15.38% since 04/22/24 | ||
| Low | 2.18 on 07/05/22 | 1.5400 on 04/29/24 | 3.74 on 04/29/24 | ||
| High | 2.20 on 07/08/22 | 1.9900 on 04/24/24 | 5.25 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | unch since 06/08/22 | -48.33% since 03/28/24 | -65.81% since 03/28/24 | ||
| Low | 2.18 on 07/05/22 | 1.5400 on 04/29/24 | 3.74 on 04/29/24 | ||
| High | 2.20 on 07/08/22 | 3.1600 on 04/02/24 | 11.20 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +18.38% since 04/08/22 | -51.56% since 01/29/24 | +8.41% since 01/29/24 | ||
| Low | 1.75 on 05/18/22 | 1.5400 on 04/29/24 | 3.18 on 02/02/24 | ||
| High | 2.20 on 07/08/22 | 3.4700 on 01/31/24 | 11.42 on 03/26/24 | ||
| 6-Month | |||||
| %Chg | +7.88% since 01/07/22 | +34.78% since 10/27/23 | +88.89% since 10/27/23 | ||
| Low | 1.40 on 02/01/22 | 1.1500 on 10/30/23 | 1.61 on 11/13/23 | ||
| High | 2.20 on 07/08/22 | 3.5299 on 01/23/24 | 11.42 on 03/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 104,796 | 105,698 | 104,454 | ||
| Shares Outstanding, K | 47,852 | 64,450 | 25,791 | ||
| Annual Sales | 0 | 10,000 | 572,430,000 | ||
| Annual Net Income | -47,140,000 | -36,900,000 | -105,140,000 | ||
| Last Quarter Sales | 0 | 10,000 | 135,500,000 | ||
| Last Quarter Net Income | -15,262,000 | -9,080,000 | -15,390,000 | ||
| 60-Month Beta | 1.33 | 2.18 | 3.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 04/27/22 | -0.14 on 03/27/24 | -0.60 on 02/07/24 | ||
| Latest Earnings Date | 08/10/22 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||